Marketed as Journavx, the novel, non-opioid therapy becomes the first new class of medicine to treat acute pain in over 20 years. 1. The new drug …
Source: pain relief
“I think in acute pain this drug has great promise,” said Michael Schatman, a clinical instructor in the department of anesthesiology, perioperative …
Source: best pain reliever
This FDA approval of suzetrigine, an investigational non-opioid pain signal inhibitor, may help to address the needs of patients with …
Source: pain relief
The Food and Drug Administration approved Vertex Pharmaceuticals' non-opioid painkiller pill, a new alternative for pain relief that comes without …
Source: pain relief